Dusigitumab Biosimilar – Anti-IGF1, IGF2 mAb – Research Grade

Reference:
Product nameDusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade
SourceCAS 1204390-13-5
SpeciesHomo sapiens
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDusigitumab,MEDI-573,IGF1, IGF2,anti-IGF1, IGF2
ReferencePX-TA1310
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-nd
ClonalityMonoclonal Antibody

Description of Dusigitumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade

General information on Anti-IGF1/IGF2[Homo sapiens] (Dusigitumab) Monoclonal Antibody

Dusigitumab has been investigated for the treatment of Cancer, Advanced Solid Malignancies, Unresectable or Metastatic Hepatocellular Carcinoma (HCC), and Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Dusigitumab Biosimilar – Anti-IGF1, IGF2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human IGF1 recombinant protein
Antigen

Human IGF1 recombinant protein

PX-P6251 500$
Human IgG2 Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG2 Isotype Control antibody (HyHEL-10)

PTX17900 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products